Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

Aim. To evaluate the effectiveness of preventive and prophylactic post-transplantation therapy using azacitidine (5-AZA) in patients at high risk of post-transplantation relapse. Methods. 136 patients were included in the study performed by the pairwise comparison: 68 of them received 5-AZA after...

Full description

Bibliographic Details
Main Authors: VN Ovechkina, SN Bondarenko, EV Morozova, IS Moiseev, OA Slesarchuk, AG Smirnova, OS Uspenskaya, YaV Gudozhnikova, AA Osipova, VS Sergeev, NN Mamaev, LS Zubarovskaya, BV Afanas’ev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-01-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
acute myeloblastic leukemia
myelodysplastic syndrome
allogeneic hematopoietic stem cell transplantation
hypomethylating therapy
azacitidine
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/01/6.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2017/01/6.pdf

Similar Items